| 1 |
35530342 | Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report. | 2022 |
2 |
| 2 |
33348023 | Anlotinib enhances the antitumor activity of radiofrequency ablation on lung squamous cell carcinoma. | 2021 Feb |
1 |
| 3 |
32266457 | A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors. | 2020 May |
1 |
| 4 |
32587778 | Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling. | 2020 May 15 |
1 |
| 5 |
32724339 | Anlotinib as a molecular targeted therapy for tumors. | 2020 Aug |
2 |
| 6 |
32987493 | Bronchial Fistula: Rare Complication of Treatment with Anlotinib. | 2020 Oct 20 |
2 |
| 7 |
30032842 | Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer. | 2018 Aug |
1 |
| 8 |
27716285 | Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. | 2016 Oct 4 |
1 |